Time
|
Duration
|
Type
|
Presenting person
|
Title
|
September 19th, Wednesday |
|
09:30 |
Sesja 5: Biochemia nowotworów |
09:30 |
00:40:00 |
Wykład |
Grzegorz Bartosz |
Oxidative stress and cancer |
10:10 |
00:40:00 |
Wykład |
Katarzyna Piwocka |
Aneuploidy and cancer; Bcr-Abl expression leads to compromised mitotic spindle checkpoint promoting chromosomal instability |
10:50 |
00:40:00 |
Wykład |
Andrzej M. Składanowski |
From chemoresistance to cancer stem cells: the case of BRCP/ABCG2 half transporter |
11:30 |
Przerwa |
12:00 |
00:40:00 |
Wykład |
Stanisław Szala |
Tumor blood vessels – a target for anticancer therapy |
12:40 |
00:20:00 |
Wykład |
Izabela Sacewicz |
Influence of DNAzymes to β1 integrin subunit on tumoral neovascularisation |
13:00 |
00:20:00 |
Wykład |
Barbara Krawczyk |
Epigenetic therapy - modulation of the effects of nucleoside analogues on methylation and expression of selected tumour suppressor genes by natural compounds in breast cancer cells |
13:20 |
00:20:00 |
Wykład |
Anna Jankowska |
Reduction of hCGß gene expression in HeLa cell line by modified U1 snRNA |
13:40 |
00:20:00 |
Wykład |
Halina M. Waś |
Role of HO-1 in chemically induced carcinogenesis in mice |
14:30 |
Sesja plakatowa |
14:30 |
#P5.1 |
Poster |
Karol Jelonek |
Polymorphism of DNA repair genes as a cancer risk factor; comparison between head and neck squamous cell carcinoma and colon cancer |
14:30 |
#P5.2 |
Poster |
Urszula Lewandowska |
The role of WWOX in normal and pathological cell metabolism |
14:30 |
#P5.3 |
Poster |
Justyna K. Broniarczyk |
Decreased level of TSG101 expression in epithelial cells at different stages of cervical cancer development is presumably not regulated by epigenetic modifications. |
14:30 |
#P5.4 |
Poster |
Katarzyna A. Szołtysek |
Expression of the YEATS protein family in human cancer tissues. |
14:30 |
#P5.5 |
Poster |
Małgorzata Presler |
Reduced expression of the ZAC mRNA in bladder cancer |
14:30 |
#P5.6 |
Poster |
Anna Krześlak |
Expression and subcellular distribution of Akt1 in thyroid lesions |
14:30 |
#P5.7 |
Poster |
Jarosław Paluszczak |
Modulation of the activity of DNA methyltransferases by plant phenolic compounds |
14:30 |
#P5.8 |
Poster |
Ludmiła Węglarz |
The influence of phytic acid on NFκB expression in human colon cancer cells |
14:30 |
#P5.9 |
Poster |
Beata Parfiniewicz |
Expression of genes of tumor necrosis factor -α and its receptors in colon cancer Caco-2 cells treated with inositol hexaphosphate |
14:30 |
#P5.10 |
Poster |
Małgorzata Kapral |
Expression of matrix metalloproteinase 2 and matrix metalloproteinase 9 in laryngeal squamous cell carcinoma |
14:30 |
#P5.11 |
Poster |
Małgorzata Wolańska |
Matrix metalloproteinases and their inhibitors of human leiomyoma in various stages of tumor growth. |
14:30 |
#P5.12 |
Poster |
Monika Mach |
The changes of actin cytoskeleton triggered by cofilin and gelsolin are correlated with high metastatic potential of human colon adenocarcinoma cells |
14:30 |
#P5.13 |
Poster |
Agata Radwańska |
Vinculin distribution accompanying to lumican-induced actin reorganization in human melanoma A375 cells |
14:30 |
#P5.14 |
Poster |
Jadwiga Snarska |
Activity of α-fucosidase in serum and urine of smoking patients with colon adenocarcinoma. |
14:30 |
#P5.15 |
Poster |
Jan Stec |
Effect of benzo(α)pyrene and aflatoxin B1 on sheep lymphocytes infected with bovine leukemia virus |
14:30 |
#P5.16 |
Poster |
Monika A. Pietrowska |
Analyses of lymphocyte radiosensitivity in vitro for identification of predictive biomarkers of early response to radiotherapy in head and neck cancer patients |
14:30 |
#P5.17 |
Poster |
Robert Nowak |
The sensitivity of immortalized hybrid endothelial-cancer cells EA.hy926 to UVC radiation in comparison with human promyelocytic leukaemia HL60 cells |
14:30 |
#P5.18 |
Poster |
Ewa Chodurek |
The thermochemolysis of melanins isolated from melanoma malignum |
14:30 |
#P5.19 |
Poster |
Magdalena Łuczak |
Application of 2-D electrophoresis and MALDI-TOF mass spectrometry for proteomic analysis of human acute myeloid leukemia cells |
14:30 |
#P5.20 |
Poster |
Łukasz Marczak |
MALDI-TOF mass spectrometry analysis of blood serum proteins for the preparation for breast cancer biomarker discovery |
14:30 |
#P5.21 |
Poster |
Leszek Szmigiero |
The effect of introduction of a formamidino group to the molecule of doxorubicin on its biological properties |
14:30 |
#P5.22 |
Poster |
Dorota Kostrzewa-Nowak |
The role of bioreductive activation of idarubicin in the cytotoxic activity against leukaemia HL60 sensitive cell line and its multidrug resistant sublines |
14:30 |
#P5.23 |
Poster |
Agnieszka A. Maruszewska |
The effect of antitumour agents, vincristine and doxorubicin, on non-enzymatic and enzymatic NADPH oxidation stimulated by pyridinium salts |
14:30 |
#P5.24 |
Poster |
Kamila Siedlecka |
Resveratrol and apoptosis in MOLT-4 human leukemia cells |
14:30 |
#P5.25 |
Poster |
Iwona Mitrus |
Use of conjugate of paclitaxel with PGA in melanoma tumour therapy in mice |
14:30 |
#P5.26 |
Poster |
Ryszard Smolarczyk |
Combination of anticancer peptide (CAMEL) with immunotherapy in B16(F10) murine melanoma tumor therapy |
14:30 |
#P5.27 |
Poster |
Andrzej Smagur |
New chimeric protein ABRaA-VEGF121 is selectively cytotoxic towards cells overexpressing VEGFR2 (KDR) and inhibits growth of primary tumors. |